Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
about
Carbon nanotubes as cancer therapeutic carriers and mediatorsCombination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.Cytotoxicity induced by carbon nanotubes in experimental malignant gliomaVaccination in the immunotherapy of glioblastoma.Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas.Evaluation of multiwalled carbon nanotube cytotoxicity in cultures of human brain microvascular endothelial cells grown on plastic or basement membrane.
P2860
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metronomic Doses of Temozolomi ...... py in an Invasive Glioma Model
@ast
Metronomic Doses of Temozolomi ...... py in an Invasive Glioma Model
@en
type
label
Metronomic Doses of Temozolomi ...... py in an Invasive Glioma Model
@ast
Metronomic Doses of Temozolomi ...... py in an Invasive Glioma Model
@en
prefLabel
Metronomic Doses of Temozolomi ...... py in an Invasive Glioma Model
@ast
Metronomic Doses of Temozolomi ...... py in an Invasive Glioma Model
@en
P2093
P2860
P1433
P1476
Metronomic Doses of Temozolomi ...... py in an Invasive Glioma Model
@en
P2093
Anna Da Fonseca
Behnam Badie
Darya Alizadeh
Edwin R Manuel
Ethan E White
Jacob M Berlin
Leying Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0148139
P407
P577
2016-02-01T00:00:00Z